Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

NICE guideline
Reference number: NG18
Published: 01 August 2015
Last updated: 11 May 2023

History

Declaration of interests

Register of interests - CYP meds (PDF 511 KB)

Published:

11 May 2023

Guidance published

Consultation comments and responses - CYP meds (PDF 618 KB)

Published:

11 May 2023
Equality impact assessment - CYP meds (1-4) (PDF 215 KB)

Published:

11 May 2023

Stakeholder list updated

Stakeholder list (PDF 291 KB)

Published:

26 April 2023

Committee list updated

Committee member list (PDF 129 KB)

Published:

21 March 2023

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 319 KB)

Published:

25 January 2023
Comments form (MSWord 41 KB)

Published:

25 January 2023
Evidence review (PDF 3.57 MB)

Published:

25 January 2023

Pre-consultation documents released

Review questions (PDF 146 KB)

Published:

16 November 2022

Committee meetings

Committee meeting
Minutes GC18 - CYP (PDF 184 KB)

Published:

31 October 2022
Minutes GC20 - CYP (PDF 200 KB)

Published:

07 March 2023

Scope published

Consultation comments and responses (PDF 341 KB)

Published:

26 October 2022
Final scope (PDF 169 KB)

Published:

04 April 2023

Draft scope consultation

Draft scope consultation
Draft scope (PDF 169 KB)

Published:

18 March 2022
Comments form (MSWord 35 KB)

Published:

18 March 2022

Update on 29 June 2022

Guidance published
Consultation comments and responses (PDF 466 KB)

Published:

29 June 2022
Committee member list (PDF 217 KB)

Published:

29 June 2022
Equality impact assessment 4 - periodontitis (PDF 148 KB)

Published:

29 June 2022
Stakeholder list updated
Stakeholder list (PDF 225 KB)

Published:

28 June 2022
Declaration of interests
Register of interests (PDF 1.24 MB)

Published:

28 June 2022
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 202 KB)

Published:

30 March 2022
Evidence review (PDF 773 KB)

Published:

30 March 2022
Equality impact assessment 3 (PDF 129 KB)

Published:

30 March 2022
Comments form (MSWord 43 KB)

Published:

30 March 2022
Committee list updated
Committee member list (PDF 201 KB)

Published:

29 March 2022
Committee meeting
Minutes 9 (PDF 184 KB)

Published:

14 April 2021
Minutes 14 (PDF 225 KB)

Published:

07 February 2022
Minutes 15 (PDF 177 KB)

Published:

09 May 2022

Update on 31 March 2022

Guidance published
Consultation comments and responses (PDF 950 KB)

Published:

31 March 2022
Committee member list (PDF 201 KB)

Published:

31 March 2022
Equality impact assessment 4 - CGM (PDF 165 KB)

Published:

31 March 2022
Stakeholder list updated
Stakeholder list (PDF 310 KB)

Published:

30 March 2022
Declaration of interests
Register of interests (PDF 1.22 MB)

Published:

30 March 2022
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 266 KB)

Published:

23 November 2021
Evidence review A (PDF 2.5 MB)

Published:

23 November 2021
Equality impact assessment 3 (PDF 127 KB)

Published:

23 November 2021
Comments form (MSWord 41 KB)

Published:

23 November 2021
Scope published
Final scope (PDF 270 KB)

Published:

19 October 2021
Pre-consultation documents released
Review questions - CGM (PDF 165 KB)

Published:

15 October 2021
Search strategies - CGM (PDF 318 KB)

Published:

15 October 2021

Update on 16 December 2020

Guidance published
Consultation comments and responses (PDF 1004 KB)

Published:

16 December 2020
Equality impact assessment 4 (PDF 107 KB)

Published:

16 December 2020
Committee member list (PDF 189 KB)

Published:

16 December 2020
Stakeholder list updated
Stakeholder list (PDF 301 KB)

Published:

15 December 2020
Declaration of interests
Register of interests (PDF 738 KB)

Published:

15 December 2020
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 107 KB)

Published:

30 November 2020
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 635 KB)

Published:

23 September 2020
Equality impact assessment 1-3 (PDF 146 KB)

Published:

23 September 2020
Evidence review (PDF 3.29 MB)

Published:

23 September 2020
Comments form (MSWord 37 KB)

Published:

23 September 2020
Committee list updated
Committee member list (PDF 179 KB)

Published:

13 November 2020
Scope published
Final scope (PDF 270 KB)

Published:

20 July 2020
Committee meeting
Minutes 1 (PDF 178 KB)

Published:

06 December 2019
Minutes 2 (PDF 182 KB)

Published:

16 March 2020
Minutes 3 (PDF 184 KB)

Published:

22 July 2020
Minutes 4 (PDF 208 KB)

Published:

05 September 2020
Minutes 5 (PDF 212 KB)

Published:

05 November 2020
Minutes 6 (PDF 199 KB)

Published:

26 November 2020

Original development on 26 August 2015

Stakeholder list updated
Stakeholder list (PDF 151 KB)

Published:

02 July 2019
Surveillance consultation
Surveillance consultation
Comments form (MSWord 29 KB)

Published:

25 April 2019
Surveillance review proposal (PDF 1.06 MB)

Published:

25 April 2019
Stakeholder comments table
Stakeholder comments table (PDF 4.21 MB)

Published:

26 August 2015
Equality impact assessment
Equality impact assessment (PDF 54 KB)

Published:

23 July 2015
Equality impact assessment (development)
Equality impact assessment (development) (PDF 218 KB)

Published:

22 July 2015
Guideline consultation
Guideline consultation information
Draft NICE guideline (PDF 691 KB)

Published:

10 December 2014
Draft guideline (PDF 4.22 MB)

Published:

10 December 2014
Appendix (PDF 4.86 MB)

Published:

10 December 2014
List of registered stakeholders
List of registered stakeholders (PDF 129 KB)

Published:

24 March 2015
Health economic plan, review questions and search strategies
Health economic plan, review questions and search strategies
Health economic plan (PDF 25 KB)

Published:

21 October 2014
Search strategies (PDF 1.28 MB)

Published:

21 October 2014
Review questions (PDF 55 KB)

Published:

21 October 2014
Diabetes in children (update): guideline development and consultation
Diabetes in children (update): guideline development and consultation
Diabetes in children (update): GDG membership list (PDF 11 KB)

Published:

07 May 2013
Diabetes in children (update): GDG minutes
GDG 13 minutes (PDF 237 KB)

Published:

21 September 2015
Diabetes in children (update): GDG 12 minutes (PDF 142 KB)

Published:

21 April 2015
Diabetes in children (update): GDG 11 minutes (PDF 139 KB)

Published:

21 April 2015
Diabetes in children (update): GDG 10 minutes (PDF 145 KB)

Published:

21 April 2015
Diabetes in children (update): GDG 9 minutes (PDF 141 KB)

Published:

21 April 2015
Diabetes in children (update): GDG 8 minutes (PDF 137 KB)

Published:

04 February 2014
Diabetes in children (update): GDG 7 minutes (PDF 144 KB)

Published:

19 November 2013
Diabetes in children (update): GDG 6 minutes (PDF 138 KB)

Published:

19 November 2013
Diabetes in children (update): GDG 5 minutes (PDF 167 KB)

Published:

19 November 2013
Diabetes in children (update): GDG 4 minutes (PDF 159 KB)

Published:

19 November 2013
Diabetes in children (update): GDG 3 minutes (PDF 157 KB)

Published:

19 November 2013
Diabetes in children (update): GDG 2 minutes (PDF 39 KB)

Published:

07 February 2013
Diabetes in children (update): GDG 1 minutes (PDF 169 KB)

Published:

07 February 2013
Diabetic ketoacidosis (DKA): meeting minutes 1 (PDF 38 KB)

Published:

02 April 2014
Diabetes in children (update): scoping workshop, consultation and final scope
Diabetes in children (update): scoping workshop, consultation and final scope
Final scope (PDF 214 KB)

Published:

22 November 2012
Stakeholder comments table (PDF 716 KB)

Published:

22 November 2012
Joint diabetes guidelines: draft scopes consultation information
Type 1 diabetes (update): draft scope (PDF 82 KB)

Published:

04 July 2012
Type 2 diabetes: draft scope (PDF 91 KB)

Published:

04 July 2012
Diabetes in children (update): draft scope (PDF 89 KB)

Published:

04 July 2012
Diabetes in pregnancy (update): draft scope (PDF 101 KB)

Published:

04 July 2012
Type 1 Diabetes (update): list of registered stakeholders (PDF 136 KB)

Published:

24 March 2015
Type 2 diabetes information
Diabetes in pregnancy (update): list of registered stakeholders (PDF 101 KB)

Published:

16 January 2015
Diabetes in children (update): scoping workshop notes (PDF 164 KB)

Published:

04 July 2012